CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 132 enrolled
Drug / intervention
Intravenous lidocaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05238506
NCT05238506Phase 4Completed

The Effect of Intravenous Lidocaine Infusion on Hemodynamic Reaction to Tracheal Intubation, as Well as Metabolic and Hormonal Response to Laparoscopic Procedure in Children: a Randomized Controlled Trial

Medical University of Warsaw·interventional·Posted Feb 14, 2022·Updated Oct 31, 2023

In Brief

A Phase 4 clinical trial evaluating Intravenous lidocaine and Normal saline infusion for Hemodynamic Response and 4 related conditions. Completed, enrolled 132 participants across 1 site.

Detailed Summary

Intravenous lidocaine - a potent local anesthetic with analgesic and anti- inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and facilitates pain management in adults. In children population promising but limited evidence is available. The study has been planned to evaluate the efficacy of continuous intravenous infusion of lidocaine in alleviation of hemodynamic reaction to tracheal intubation, as well as metabolic and hormonal response to laparoscopic procedure in children.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPoland
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedFeb 14, 2022
Enrollment StartMar 12, 2022
Primary CompletionAug 8, 2023
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 4.4 years ago

Interventions

Intravenous lidocainedrug

Intraoperative intravenous lidocaine infusion.

Normal saline infusiondrug

Intraoperative intravenous normal saline infusion.